Literature DB >> 1977725

Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis.

P T Murphy, J R O'Donnell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1977725     DOI： 10.1007/bf02937244

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  3 in total

1.  Studies of the bone marrow in immunological granulocytopenia; following administration of salicylazosulfapyridine.

Authors:  R S EVANS; W P FORD
Journal:  AMA Arch Intern Med       Date:  1958-02

2.  Agranulocytosis associated with sulphasalazine therapy.

Authors:  P Cochrane; P Atkins; S Ehsanullah
Journal:  Postgrad Med J       Date:  1973-09       Impact factor: 2.401

Review 3.  Blood dyscrasias secondary to non-steroidal anti-inflammatory drugs.

Authors:  P A Miescher
Journal:  Med Toxicol       Date:  1986
  3 in total
  1 in total

Review 1.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.